Candida auris: A Latent Threat to Critically Ill Patients with Coronavirus Disease 2019. Clin Infect Dis.
Rodriguez JY, Le Pape P, Lopez O, Esquea K, Labiosa AL, Alvarez-Moreno C. 2/11/2021.
We read the article by White et al [1] with great interest. The proposed strategy will probably elucidate the true role of coronavirus disease 2019 (COVID-19)–associated invasive fungal infections, especially COVID-19–associated pulmonary aspergillosis (CAPA). We have not found the same incidence of CAPA, probably due to the absence of an active search. However, we detected an increase in the number of fungemias in critically ill COVID-19 patients.
A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts. Int J Infect Dis.
Fay FF, Alvarez-Moreno CA, Bonvehi PE, Espinoza CC, Hidalgo MLH, Marcano-Lozada M, Perez CM, Pulchinelli A Jr, Sáenz-Flor KV, Condino- Neto A. 20/05/2021
Abstract Objective: To analyse the clinic characteristics, risk factors and evolution of the first cohort of hospitalised patients with confirmed infection by COVID-19 in 5 Colombian institutions. Conclusions: The clinical course of SARS-CoV-2 infection in hospitalized Colombian was characterised by a more advanced stage of the infection.
Clinical course, biomarkers, management and outcomes of patients hospitalised due to COVID-19 in Colombia
Yomayusa-Gonzalez N., Chacón-Acevedo, K.R., Ávila-Reina, AJ., ...Combariza-Vallejo, J.F., Álvarez-Moreno, C. 19/07/2021
Abstract Objective: To analyse the clinic characteristics, risk factors and evolution of the first cohort of hospitalised patients with confirmed infection by COVID-19 in 5 Colombian institutions.
Conclusions: The clinical course of SARS-CoV-2 infection in hospitalized Colombian was characterised by a more advanced stage of the infection.
Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant? Lancet. 12
Alvarez-Moreno C, De La Hoz Siegler I, Rojas J, Bravo Ojeda J, Chacón J, Yomayusa N, Patiño S, Gomez-Nieto K, Martínez Pinzón V, Toloza C, Tarud Ayub R, Rengifo P. 12/12/2022
Background
The third epidemic wave reported the greatest number of deaths related to SARS-CoV-2 in Colombia. In this wave, the Mu variant was predominant in 75% of the cases. Therefore, we evaluated the association between Colombia's third wave and COVID-19 all-cause inhospital mortality.
